Hugel Signs Deal to Add ECM-based Skin Regeneration Injectable to Portfolio
Agreement for CellREDM highlights growing interest in regenerative injectables used alongside fillers.
Agreement for CellREDM highlights growing interest in regenerative injectables used alongside fillers.
The ready-to-use liquid botulinum toxin treatment requires no reconstitution. Phase III trials showed improvements in frown lines, with some patients maintaining results for up to six months.